Works matching IS 13520504 AND DT 2005 AND VI 12 AND IP 3

Results: 15

Characteristic sequence changes of hepatitis C virus genotype 2b associated with sustained biochemical response to IFN therapy.

Published in:

Journal of Viral Hepatitis, 2005, v. 12, n. 3, p. 251, doi. 10.1111/j.1365-2893.2005.00511.x

By:

Tanabe, Y.;
Nagayama, K.;
Enomoto, N.;
Izumi, N.;
Tazawa, J.;
Kurosaki, M.;
Sakamoto, N.;
Sato, C.;
Watanabe, M.

Publication type:

Article

Lamivudinevslamivudine and interferon combination treatment of HBeAg(−) chronic hepatitis B.

Published in:

Journal of Viral Hepatitis, 2005, v. 12, n. 3, p. 262, doi. 10.1111/j.1365-2893.2005.00566.x

By:

Yurdaydin, C.;
Bozkaya, H.;
Çetinkaya, H.;
Şahin, T.;
Karao&gcaron;uz, D.;
Törüner, M.;
Erkan, Ö.;
Heper, A. O.;
Erden, E.;
Bozdayi, A. M.;
Uzunalimo&gcaron;lu, Ö.

Publication type:

Article

Immunomodulatory effects of selective leucocytapheresis as a new adjunct to interferon-α2b plus ribavirin combination therapy: a prospective study in patients with high plasma HCV viraemia.

Published in:

Journal of Viral Hepatitis, 2005, v. 12, n. 3, p. 274, doi. 10.1111/j.1365-2893.2005.00577.x

By:

Sawada, K.;
Masaki, N.;
Hayashi, S.;
Zeniya, M.;
Ishikawa, T.;
Takahashi, H.;
Ohnishi, K.;
Fukunaga, K.;
Hara, N.;
Yamamoto, T.;
Hada, T.;
Toda, G.

Publication type:

Article

Gamma-glutamyltransferase in fine-needle liver biopsies of subjects with chronic hepatitis C.

Published in:

Journal of Viral Hepatitis, 2005, v. 12, n. 3, p. 269, doi. 10.1111/j.1365-2893.2005.00579.x

By:

Paolicchi, A.;
Marchi, S.;
Petruccelli, S.;
Ciancia, E.;
Malvaldi, G.;
Pompella, A.

Publication type:

Article

Prevalence and sexual risk of hepatitis C virus infection when human immunodeficiency virus was acquired through sexual intercourse among patients of the Lyon University Hospitals, France, 1992–2002.

Published in:

Journal of Viral Hepatitis, 2005, v. 12, n. 3, p. 330, doi. 10.1111/j.1365-2893.2005.00583.x

By:

D'Oliveira, A.;
Voirin, N.;
Allard, R.;
Peyramond, D.;
Chidiac, C.;
Touraine, J.-L.;
Fabry, J.;
Trepo, C.;
Vanhems, P.

Publication type:

Article

HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.

Published in:

Journal of Viral Hepatitis, 2005, v. 12, n. 3, p. 325, doi. 10.1111/j.1365-2893.2005.00586.x

By:

Momosaki, S.;
Nakashima, Y.;
Kojiro, M.;
Tabor, E.

Publication type:

Article

Inhibition of hepatitis B virus replication in 2.2.15 cells by expressed shRNA.

Published in:

Journal of Viral Hepatitis, 2005, v. 12, n. 3, p. 236, doi. 10.1111/j.1365-2893.2005.00587.x

By:

Ren, X.-R.;
Zhou, L.-J.;
Luo, G.-B.;
Lin, B.;
Xu, A.

Publication type:

Article

Mutations in the E2–PePHD region of hepatitis C virus type 1b in patients with hepatocellular carcinoma.

Published in:

Journal of Viral Hepatitis, 2005, v. 12, n. 3, p. 243, doi. 10.1111/j.1365-2893.2005.00589.x

By:

Bagaglio, S.;
Mitri, M. S.;
Lodrini, S.;
Paties, C.;
Cassini, R.;
Bianchi, G.;
Bernardi, M.;
Lazzarin, A.;
Morsica, G.

Publication type:

Article

Comparison of a 6-month course peginterferonα-2b plus ribavirin and interferonα-2b plus ribavirin in treating Chinese patients with chronic hepatitis C in Taiwan.

Published in:

Journal of Viral Hepatitis, 2005, v. 12, n. 3, p. 283, doi. 10.1111/j.1365-2893.2005.00590.x

By:

Lee, S.-D.;
Yu, M.-L.;
Cheng, P.-N.;
Lai, M.-Y.;
Chao, Y.-C.;
Hwang, S.-J.;
Chang, W.-Y.;
Chang, T.-T.;
Hsieh, T.-Y.;
Liu, C.-J.;
Chen, D.-S.

Publication type:

Article

A randomized controlled trial of pegylated interferonα-2a (40 KD) or interferonα-2a plus ribavirin and amantadinevsinterferonα-2a and ribavirin in treatment-naïve patients with chronic hepatitis C.

Published in:

Journal of Viral Hepatitis, 2005, v. 12, n. 3, p. 292, doi. 10.1111/j.1365-2893.2005.00591.x

By:

Mangia, A.;
Ricci, G. L.;
Persico, M.;
Minerva, N.;
Carretta, V.;
Bacca, D.;
Cela, M.;
Piattelli, M.;
Annese, M.;
Maio, G.;
Conte, D.;
Guadagnino, V.;
Pazienza, V.;
Festi, D.;
Spirito, F.;
Andriulli, A.

Publication type:

Article

Detection of multiple hepatitis C virus genotypes in a cohort of injecting drug users.

Published in:

Journal of Viral Hepatitis, 2005, v. 12, n. 3, p. 322, doi. 10.1111/j.1365-2893.2005.00592.x

By:

Bowden, S.;
McCaw, R.;
White, P. A.;
Crofts, N.;
Aitken, C. K.

Publication type:

Article

Determinants of acquiring hepatitis A virus disease in a large Italian region in endemic and epidemic periods.

Published in:

Journal of Viral Hepatitis, 2005, v. 12, n. 3, p. 315, doi. 10.1111/j.1365-2893.2005.00593.x

By:

Lopalco, P. L.;
Malfait, P.;
Menniti-Ippolito, F.;
Prato, R.;
Germinario, C.;
Chironna, M.;
Quarto, M.;
Salmaso, S.

Publication type:

Article

Apoptotic cytokeratin 18 neoepitopes in serum of patients with chronic hepatitis C.

Published in:

Journal of Viral Hepatitis, 2005, v. 12, n. 3, p. 307, doi. 10.1111/j.1365-2893.2005.00594.x

By:

Kronenberger, B.;
Wagner, M.;
Herrmann, E.;
Mihm, U.;
Piiper, A.;
Sarrazin, C.;
Zeuzem, S.

Publication type:

Article

Treatment of hepatitis C.

Published in:

Journal of Viral Hepatitis, 2005, v. 12, n. 3, p. 223, doi. 10.1111/j.1365-2893.2005.00600.x

By:

Heathcote, J.;
Main, J.

Publication type:

Article

The efficacy and safety of thymosin alpha-1 in Japanese patients with chronic hepatitis B; results from a randomized clinical trial.

Published in:

Journal of Viral Hepatitis, 2005, v. 12, n. 3, p. 300, doi. 10.1111/j.1365-2893.2005.00633.x

By:

Iino, S.;
Toyota, J.;
Kumada, H.;
Kiyosawa, K.;
Kakumu, S.;
Sata, M.;
Suzuki, H.;
Martins, E. B.

Publication type:

Article